Evidence map›Paper›PMID 28356392›Full record

ArticleThe Journal of experimental medicine2017

BATF2 inhibits immunopathological Th17 responses by suppressing

Shoko Kitada, Hisako Kayama, Daisuke Okuzaki, Ritsuko Koga, Masao Kobayashi, Yasunobu Arima, Atsushi Kumanogoh, Masaaki Murakami, Masahito Ikawa, Kiyoshi Takeda

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. BATF2 enhances proinflammatory cytokine responses in macrophages and improves early host defense against pulmonaryAmerican journal of physiology. Lung cellular and molecular physiology · 2023
    Article
  7. Article
  8. Article
  9. Identifying key genes in CD4Frontiers in genetics · 2022
    Article
  10. Article
  11. Review
  12. The Blockade of Interleukin-2 During the Acute Phase ofFrontiers in cellular and infection microbiology · 2021
    Article
  13. Article
  14. Interleukin-17 mediated immunity during infections with Trypanosoma cruzi and other protozoans.Biochimica et biophysica acta. Molecular basis of disease · 2020
    Article
  15. SARI prevents ocular angiogenesis and inflammation in mice.Journal of cellular and molecular medicine · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Heme ameliorates dextran sodium sulfate-induced colitis through providing intestinal macrophages with noninflammatory profiles.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Shoko KitadaDepartment of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.
Hisako KayamaDepartment of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.ORCID 0000-0001-5676-8228
Daisuke OkuzakiDNA-Chip Developmental Center for Infectious Diseases, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan.ORCID 0000-0002-4552-783X
Ritsuko KogaDepartment of Molecular Genetics, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan.
Masao KobayashiDepartment of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.
Yasunobu ArimaDivision of Molecular Neuroimmunology, Institute for Genetic Medicine, Graduate School of Medicine, Hokkaido University, Sapporo 060-8638, Japan.
Atsushi KumanogohDepartment of Respiratory Medicine, Allergy and Rheumatic Diseases, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.
Masaaki MurakamiDivision of Molecular Neuroimmunology, Institute for Genetic Medicine, Graduate School of Medicine, Hokkaido University, Sapporo 060-8638, Japan.
Masahito IkawaDepartment of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan.ORCID 0000-0001-9859-6217
Kiyoshi TakedaDepartment of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan ktakeda@ongene.med.osaka-u.ac.jp.ORCID 0000-0002-1778-6332
The University of Osaka · JPJapan Agency for Medical Research and Development · JPHokkaido University · JPKyushu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inappropriate IL-17 responses are implicated in chronic tissue inflammation. IL-23 contributes to

Indexed as

AnimalsBasic-Leucine Zipper Transcription FactorsChagas DiseaseFemaleImmunity, InnateInterleukin-23 Subunit p19MiceMice, Inbred C57BLMice, KnockoutProto-Oncogene Proteins c-junTh17 CellsTrypanosoma cruziBasic-Leucine Zipper Transcription FactorsBATF2 protein, mouseIl23a protein, mouseInterleukin-23 Subunit p19Proto-Oncogene Proteins c-jun

Identifiers

PMID28356392
PMCPMC5413328
OpenAlexW2603491638

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.